Farrerol suppresses epithelial-mesenchymal transition in hepatocellular carcinoma via suppression of TGF-β1/Smad2/3 signaling

Overall, farrerol suppresss HCC by inhibiting migration, invasiveness, the EMT, and angiogenesis, implying that farrerol could be a promising antimetastasis agent for HCC.

Authors

Institutions

Publication Details

Journal
Pathology - Research and Practice
Published
2024-11-08
DOI
https://doi.org/10.1016/j.prp.2024.155719
Citations
7
Primary Topic
TGF-β signaling in diseases
Type
article
Field-Weighted Citation Impact
1.64
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Farrerol suppresses epithelial-mesenchymal transition in hepatocellular carcinoma via suppression of TGF-β1/Smad2/3 signaling

Xiufeng Gu, Yaming Hao, Zhixiong Long
7 citations
Pathology - Research and Practice
TGF-β signaling in diseases
1.64
article

Farrerol suppresses epithelial-mesenchymal transition in hepatocellular carcinoma via suppression of TGF-β1/Smad2/3 signaling

Xiufeng Gu, Yaming Hao, Zhixiong Long
article en
7 citations

Abstract

Overall, farrerol suppresss HCC by inhibiting migration, invasiveness, the EMT, and angiogenesis, implying that farrerol could be a promising antimetastasis agent for HCC.

Pathology - Research and PracticeVol. 264
Hubei University of Chinese Medicine (CN), Wuhan University (CN), Wuhan City Chinese Medicine Hospital (CN), Fifth Hospital In Wuhan (CN)
Openalex Percentile: Top 16%
TGF-β signaling in diseases
1.64
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.